«Now that we have a better understanding of how an
animal is built we can get some way closer to knowing how the human
body works in health and disease,» says John Sulston, director of the Sanger
Centre at the Wellcome Trust Genome Campus, Cambridgeshire, England.
In collaboration with the United States Department of Agriculture (USDA), researchers in the UPV / EHU's «Nutrition and Obesity» Group, which belongs to the Spanish Biomedical Research
Centre in Physiopathology of Obesity and Nutrition (CIBERobn) of the Carlos III Institute of Health, have observed in
animal models that its administration reduces the build - up of
body fat, which could reduce the risk of developing other diseases like diabetes.